![Todd Simpson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Todd Simpson
Direttore/Membro del Consiglio presso
XENCOR, INC.
Patrimonio netto: - $ in data 31/05/2026
Profilo
Attualmente, Todd E. Simpson è presidente di Neoleukin Therapeutics, Inc. e direttore finanziario di Seagen Inc. Simpson fa anche parte del consiglio di Cascadian Therapeutics, Inc. e della Washington Biotechnology & Biomedical Association. Nella sua carriera passata ha ricoperto la posizione di CFO, VP-Finance & Administration presso Vericel Corp., Tesoriere presso Integra LifeSciences Holdings Corp. e Chief Financial Officer & Vice President di Telios Pharmaceuticals, Inc. (una consociata di Integra LifeSciences Holdings Corp.), CFO e VP-Finance & Administration presso AmpliPhi Biosciences Corp. e Principal presso Ernst & Young LLP. Si è laureato alla Oregon State University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
XENCOR, INC. -.--% | 28/02/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Ultime notizie su Todd Simpson
Posizioni attive di Todd Simpson
| Società | Posizione | Inizio |
|---|---|---|
| XENCOR, INC. | Direttore/Membro del Consiglio | 13/03/2025 |
Shape Therapeutics, Inc.
 Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Direttore/Membro del Consiglio | 25/06/2024 |
Inovia Capital (US), Inc.
 Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Consulente / Consigliere | 01/01/2017 |
Precedenti posizioni note di Todd Simpson
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Direttore Finanziario/CFO | 14/12/2022 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Direttore Finanziario/CFO | 01/10/2005 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Direttore Finanziario/CFO | 01/10/2001 |
| VERICEL CORPORATION | Direttore Finanziario/CFO | 01/10/2001 |
| INTEGRA LIFESCIENCES HOLDINGS CORPORATION | Treasurer | 01/12/1995 |
Formazione di Todd Simpson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
86
Relazioni di 1° grado
15
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 15 |
|---|---|
Telios Pharmaceuticals, Inc.
 Telios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceuticals, research | Health Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
Integra LifeSciences Holdings Corp.
 Integra LifeSciences Holdings Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices, implants and biomaterials | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Xencor, Inc.
 Xencor, Inc. BiotechnologyHealth Technology Develops therapeutics to treat autoimmune and allergic diseases, cancer and other conditions | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Oregon State University
 Oregon State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Washington Biotechnology & Biomedical Association
 Washington Biotechnology & Biomedical Association Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit trade association that supports and promotes the life sciences industry | Commercial Services |
Aquinox Pharmaceuticals, Inc.
 Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in identification and development of therapeutics for inflammatory diseases and cancer | Health Technology |
Inovia Capital (US), Inc.
Inovia Capital (US), Inc. Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shape Therapeutics, Inc.
Shape Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule, topical histone deacetylase inhibitor for the treatment of cutaneous t-cell lymphoma | Health Technology |
Neoleukin Therapeutics, Inc. /old/
 Neoleukin Therapeutics, Inc. /old/ Pharmaceuticals: MajorHealth Technology Develops medicines that transform lives | Health Technology |
Neoleukin Therapeutics, Inc.
 Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
